polyglutamate paclitaxel or observation only in treating patients with stage III or stage IV
ovarian epithelial or peritoneal cancer or fallopian tube cancer. Drugs used in
chemotherapy, such as paclitaxel and polyglutamate paclitaxel, work in different ways to
stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Paclitaxel and polyglutamate paclitaxel may also stop the growth of ovarian
epithelial or peritoneal cancer by blocking blood flow to the tumor. Sometimes, after
treatment, the tumor may not need additional treatment until it progresses. In this case,
observation may be sufficient. It is not yet known whether paclitaxel is more effective than
polyglutamate paclitaxel or observation only in treating ovarian epithelial, peritoneal, or
fallopian tube cancer.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: email@example.com
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.